Lipid peroxidation and inflammatory molecules as markers of coronary artery disease

被引:10
作者
Sottero, Barbara
Pozzi, Roberto
Leonarduzzi, Gabriella
Aroasio, Emiliano
Gamba, Paola
Gargiulo, Simona
Rabajoli, Filippo
Ferrari, Fabio
Lucchina, Pietro Greco
Poli, Giuseppe [1 ]
机构
[1] Univ Turin, Dept Clin & Biol Sci, San Luigi Gonzaga Hosp, I-10043 Turin, Italy
[2] San Luigi Gonzaga Hosp, Div Cardiol, I-10043 Turin, Italy
[3] San Luigi Gonzaga Hosp, Clin Biochem Lab, I-10043 Turin, Italy
关键词
oxidized low density lipoproteins; coronary artery disease; lipid peroxidation; 4-hydroxynonenal;
D O I
10.1179/135100007X162275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Oxidized low density lipoproteins (oxLDLs) may exert several pro-inflammatory effects that can contribute to the development of coronary artery disease (CAD). Evaluating a possible correlation between oxLDLs and clinical expression of CAD, we measured specific lipid peroxidation indices in healthy subjects and in patients at different clinical stages of CAD. We observed a slight, but not significant, increase in plasma content of cholesterol oxidation products, i.e. oxysterols, in all CAD patients, and a slight, but not significant, increase of 4-hydroxynonenal-protein adducts only in subjects with acute CAD. Moreover, CAD patients showed a plasma rise of specific inflammatory proteins, i.e. C-reactive protein, intercellular adhesion molecule-1, and interleukin-8, but not of monocyte chemotactic protein-1. These preliminary data, without excluding an involvement of oxidative stress and inflammation in CAD, do not show a strict correlation between relevant plasma markers, other than C-reactive protein, and acute phase of the disease.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 17 条
[1]
The vulnerable atherosclerotic plaque - Pathogenesis and therapeutic approach [J].
Aikawa, M ;
Libby, P .
CARDIOVASCULAR PATHOLOGY, 2004, 13 (03) :125-138
[2]
Adhesion molecules and atherosclerosis [J].
Blankenberg, S ;
Barbaux, S ;
Tiret, L .
ATHEROSCLEROSIS, 2003, 170 (02) :191-203
[3]
Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein [J].
Chang, YH ;
Abdalla, DSP ;
Sevanian, A .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (02) :202-214
[4]
Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease [J].
Faviou, E ;
Vourli, G ;
Nounopoulos, C ;
Zachari, A ;
Dionyssiou-Asteriou, A .
FREE RADICAL RESEARCH, 2005, 39 (04) :419-429
[5]
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[6]
Garcia-Cruset S, 2002, CHOLESTEROL AND PHYTOSTEROL OXIDATION PRODUCTION: ANALYSIS, OCCURRENCE, AND BIOLOGICAL EFFECTS, P241
[7]
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].
Hansson, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695
[8]
MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH ATHEROSCLEROTIC DISEASE [J].
HOLVOET, P ;
PEREZ, G ;
ZHAO, Z ;
BROUWERS, E ;
BERNAR, H ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2611-2619
[9]
C-reactive protein: Risk marker or mediator in atherothrombosis? [J].
Jialal, I ;
Devaraj, S ;
Venugopal, SK .
HYPERTENSION, 2004, 44 (01) :6-11
[10]
Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase [J].
Kaplan, M ;
Aviram, M .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (08) :777-787